SEC Form 4 · Insider disclosures

Recent Insider Buying

Recent purchases grouped by company. A P-code purchase may be open-market or private; check the filing for context.

Updates delayedUpdated Some disclosures are unavailable

Purchase rows791
Sale rows3,373
Purchase value (USD)US$649.43M
Sale value (USD)US$72.39B

Recent company disclosures

1 companies · 1 rows
LAB

STANDARD BIOTOOLS INC.

Purchase total ≈ US$46.9K

1 transaction rows · 1 filings

Carey Thomas D.

Purchase
Director disclosed purchase of 75,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 21.77%; approximately 419K shares afterward

Calculated transaction value approximately US$46.9K
Sources, coverage & updates
SEC filing dates: 2026-11-04 — 2026-11-13 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Nov 11, 7:34 PM ET

Partial coverage; backfill in progress

Discovered filings 3,950 · Parsed 3,950 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 95 unavailable, unverified or non-USD amounts are excluded. 1836 filings · 1788 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗